Single-Nucleus RNA-Seq Atlas of Colorectal Cancer Across the Age Continuum

A single-nucleus RNA-sequencing atlas spanning 189 primary colorectal cancer tumors across eight decades of life has revealed distinct transcriptomic features linked to age. Archived under BioProject PRJNA1378049, the study provides a high-resolution window into early-onset versus average-onset colorectal malignancies.

In Plain English: The Clinical Takeaway

• Cellular Mapping: Researchers isolated roughly 12,000 nuclei per sample using the 10x Chromium platform, mapping epithelial, immune, and stromal cells to see how tumor microenvironments shift across different age groups.
• Microsatellite Stratification: The cohort size permitted effective tumor stratification by microsatellite instability (MSI) status and tumor location (sidedness), treating age continuously rather than as a rigid binary.

Mapping the Tumor Microenvironment Across Eight Decades

Understanding why colorectal cancer diagnoses are rising among younger adults requires looking deep inside the cellular architecture of the tumors themselves. To build this comprehensive resource, tissue samples were collected from patients undergoing resection under institutional review board protocols. Following manual tissue dissociation and nuclei isolation, the genetic material was sequenced on an Illumina NovaSeq 6000 platform. Raw sequencing files were processed using Cell Ranger and Scanpy, filtering out low-quality droplets and ambient RNA to ensure maximum fidelity.

The resulting single-nucleus RNA-seq atlas allows scientists to compare tumors from patients under 50 years old—classified as early-onset colorectal cancer (EO-CRC)—with those diagnosed later in life (AO-CRC). By evaluating gene expression count matrices and applying harmony integration for batch correction, the research team identified granular epithelial subsets and lineage-level compositional shifts. The dataset provides access to processed series matrices and raw FASTQ files, enabling independent re-analyses by gastrointestinal cancer researchers worldwide.

Evaluating Molecular Subtypes and Copy Number Variations

To determine how age influences tumor biology, the investigators classified each sample’s Consensus Molecular Subtype using established single-sample prediction algorithms. They also ran inferCNV to detect somatic copy number alterations (CNA) across epithelial cells, utilizing nonepithelial cells as a baseline reference. Statistical associations between age cohorts and clinical metadata were evaluated using Fisher’s exact test and statsmodels.

Parameter	Methodology	Key Tools
Sequencing Platform	Single-nucleus RNA-seq (10x 3′ v3.1)	Illumina NovaSeq 6000
Cohort Size	189 primary tumor samples	N/A
Bioinformatics Pipeline	Quality control, clustering	Scanpy, Cell Ranger, inferCNV
Subtype Classification	Consensus Molecular Subtype assignment	CMScaller, decoupleR

Contraindications & When to Consult a Doctor

Patients experiencing persistent changes in bowel habits, unexplained rectal bleeding, iron deficiency anemia, or abdominal discomfort should seek prompt evaluation by a gastroenterologist. Diagnostic colonoscopy remains the gold standard for detecting early-onset lesions, and individuals with a family history of colorectal cancer or hereditary cancer syndromes should discuss customized screening timelines with their healthcare provider.

Photo: usebiotransfer.org

Future Directions in Early-Onset Oncology

The release of this comprehensive atlas opens new avenues for investigating the molecular drivers behind malignancies in younger populations. By establishing a robust, ethically approved biorepository linked to detailed clinical metadata, researchers can continue probing the exact cellular vulnerabilities unique to early-onset disease. The ongoing challenge for the oncology community involves translating these single-cell transcriptomic insights into targeted therapeutic interventions that can alter clinical outcomes for patients across the entire age continuum.

More on this story: Cross-Study Phenotyping and Biomarker Analysis of CAR T-Cell Therapy in ZUMA Trials

More on Colorectal Cancer: High-Dose Omega-3 Supplements Improve Survival in Colorectal Cancer Surgery